
2.48 Delayed Data As of Jan 27 | ![]() Today’s Change | 0.46 Today|||52-Week Range 4.68 | +28.50% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +222.58% increase from the last price of 2.48.
The current consensus among 4 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.